Omega-3 Fatty Acid

DENVER — Omega-3 fatty acid supplements may improve vision in patients with dry age-related macular degeneration and Stargardt disease, according to a study.

Among healthy individuals, omega-3 and omega-6 fatty acids counteracted respiratory responses to low ambient air pollution levels, researchers reported in the Annals of the American Thoracic Society.

In the second part of a five-part series, Elizabeth Yeu, MD, discusses remote learning, the incorporation of technology in education, and how dry eye disease and symptomatology are affected.

In the first part of a five-part series, Elizabeth Yeu, MD, FACS, discusses some of the ways the modern workplace can affect and exacerbate eye diseases and offers tips for relief for those who experience increased symptoms.

In a cohort of generally healthy, active, vitamin D-replete older adults, supplemental omega-3 fatty acids spurred a modest benefit in reducing falls, data from the DO-HEALTH trial show.

Older adults who took vitamin D with or without omega-3 fatty acid supplementation had a significantly lower rate of autoimmune disease over 5 years compared with those who took placebo, according to findings published in The BMJ.

In a new analysis of the REDUCE-IT trial, the treatment effect of icosapent ethyl was consistent across different agents and categories of statins patients were taking.

Healio Psychiatry’s five most-viewed stories of the year highlight a study on omega-3 supplementation and stress-related accelerated aging, research into the benefits of cannabidiol for frontline health care workers and data on the link between OCD and increased risk for dementia/Alzheimer’s disease.

Daily use of omega-3 in older adults at risk for depression correlated with a slight increase in depressive symptoms while having no effect on mood, according to a randomized clinical trial published in JAMA.

New analyses from the REDUCE-IT study show icosapent ethyl significantly reduced total primary CV endpoints by 32% in patients with prior peripheral artery disease, suggesting substantial benefit for a high-risk population.